WallStSmart
PEN

Penumbra Inc

NYSE: PEN · HEALTHCARE · MEDICAL DEVICES

$324.82
-0.36% today

Updated 2026-04-29

Market cap
$12.79B
P/E ratio
71.96
P/S ratio
9.11x
EPS (TTM)
$4.53
Dividend yield
52W range
$221 – $362
Volume
0.6M

Penumbra Inc (PEN) Earnings

Quarterly earnings history, analyst estimates, and stock price reaction.

EPS beat streak
8 of 8
Last 8 quarters
Avg EPS surprise
+6.4%
Last 4 quarters
Revenue YoY growth
+22.1%
Most recent quarter
EPS YoY growth
+21.6%
Most recent quarter

Earnings surprise history (last 12 quarters)

Beat estimate Missed estimate

Quarterly EPS and revenue trend

Quarterly revenue EPS (diluted)

How the stock reacts to earnings

Avg 1-day reaction
+7.9%
Last 3 reports
Positive reaction rate
100%
3 of 3 quarters
Largest single-day move
+12.6%
2025-11-05
Report dateEPS actualSurpriseClose beforeClose after1-day reaction
2026-02-25$1.18+7.3%$339.59$341.94+0.7%
2025-11-05$0.97+4.7%$235.08$264.61+12.6%
2025-07-29$0.86+3.6%$230.17$254.21+10.4%

Quarterly earnings history

Fiscal quarter endingEPS estimateEPS actualSurpriseRevenueYoY revenue
2025-12-31$1.10$1.18+7.3%$385.38M+22.1%
2025-09-30$0.93$0.97+4.7%$354.69M+17.8%
2025-06-30$0.83$0.86+3.6%$339.45M+13.4%
2025-03-31$0.75$0.83+10.0%$324.14M+16.3%
2024-12-31$0.89$0.97+8.5%$315.52M+10.8%
2024-09-30$0.69$0.85+23.2%$301.04M+11.1%
2024-06-30$0.56$0.64+14.3%$299.40M+14.5%
2024-03-31$0.38$0.41+7.9%$278.65M
2023-12-31$0.70$0.76+8.6%$284.68M
2023-09-30$0.45$0.67+48.9%$270.95M
2023-06-30$0.28$0.43+53.6%$261.50M

Frequently asked questions

Has Penumbra Inc beaten earnings estimates?
Penumbra Inc has beaten Wall Street EPS estimates in 8 of its last 8 quarterly reports, with an average EPS surprise of +6.4% over the last 4 quarters.
How does PEN stock react to earnings?
PEN stock has moved an average of +7.9% in the trading day following earnings over its last 3 reports, with positive reactions in 100% of those quarters.
What is Penumbra Inc's revenue growth rate?
Penumbra Inc reported year-over-year revenue growth of +22.1% in its most recent quarter, with EPS growing +21.6% year-over-year.